Skip to main content
. 2015 Dec;53(6):844–852. doi: 10.1165/rcmb.2015-0015OC

Figure 4.

Figure 4.

Percentage of total exon IX and exon VIb mRNA splice variants remaining over time in the presence/absence of IL-13 (10 ng/ml for 1 h), followed by actinomycin (Act) D (5 μg/ml) (n = 6). All data are expressed as normalized to β-glucuronidase.